STRS Ohio’s Skye Bioscience SKYE Stock Holding History

STRS Ohio’s Portfolio SKYE Stock Details SKYE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,200	Closed	-$12.5K	–	2079
2024 Q3	$12.5K	Hold	3,200	–	–	﹤0.01%	1919
2024 Q2	$25.6K	Buy	+3,200	New	+$38K	﹤0.01%	1875

Other funds holding SKYE

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

STRS Ohio's SKYE Position: Q4 2024 in Review

STRS Ohio sold out of Skye Bioscience (SKYE) in Q4 2024, closing a stake of 3,200 shares — an estimated $12.5K sold.

STRS Ohio first reported a position in SKYE in Q2 2024 and held it in 2 quarters. The position peaked at $25.6K in Q2 2024. 73 funds tracked by Wall St. Rank hold SKYE as of Q4 2024.

STRS Ohio reported no remaining Skye Bioscience position as of Q4 2024 after selling out during the quarter.
STRS Ohio sold 3,200 Skye Bioscience shares in Q4 2024, an estimated $12.5K.
STRS Ohio first reported a position in Skye Bioscience in Q2 2024 and held it in 2 quarters.
STRS Ohio's Skye Bioscience position peaked at $25.6K in Q2 2024.
73 funds tracked by Wall St. Rank held Skye Bioscience as of Q4 2024.

Based on STRS Ohio's 13F filing for Q4 2024, filed 28 May 2025.